Seven indications. One drug class. Zero access. GLP-1 receptor agonists are transforming cardiometabolic care — with evidence spanning diabetes, obesity, and cardiovascular risk reduction. So why […]

🫀 Modern Strategies in the Management of Resistant Hypertension Resistant hypertension remains a major clinical challenge — increasing cardiovascular risk despite multiple therapies. Join the Kenya […]